Acute Liver Failure: The Path Towards No Mortality
Comprehensive Lecture Summary
1. Main Clinical Topics Discussed
- Definition, classification, and diagnostic criteria for Acute Liver Failure (ALF) and Acute Liver Injury (ALI)
- Etiology-specific recognition and management of ALF
- Prognostic tools and criteria for ALF
- Two illustrative clinical cases demonstrating diagnostic reasoning in ALF
2. Key Learning Points, Guidelines, and Recommendations
Definition and Classification
- ALF = Acute liver injury + INR ≥1.5 + any degree of hepatic encephalopathy in a patient without pre-existing liver disease
- Severe ALI = INR >2.2 without encephalopathy — a critically important intermediate category
- The speaker emphasizes that waiting for encephalopathy to diagnose ALF may critically narrow the therapeutic window
- Exceptions allowing ALF diagnosis in pre-existing liver disease:
- Wilson disease
- Hepatitis B flare
- Autoimmune hepatitis
- Budd-Chiari syndrome (per EASL guidelines)
Etiology-Specific Pearls
Acetaminophen (Paracetamol) Toxicity:
- Number one cause of ALF in the United States
- Low or absent serum acetaminophen level does not rule out toxicity
- Classic biochemical pattern: AST/ALT ~3,000–4,000 U/L
- Rising serum phosphorus = progressive hepatic necrosis → poor prognosis
- Falling serum phosphorus = hepatic regeneration → improving prognosis
- Early rise in Alpha-Fetoprotein (AFP) = marker of hepatic regeneration → favorable prognosis
Wilson Disease:
- Among the worst outcomes in ALF; should prompt urgent consideration of transplant referral
- Diagnostic rationale: Ceruloplasmin is unreliable in acute settings (acute phase reactant)
- Validated diagnostic ratios:
- AST/ALT ratio >2.2 → sensitivity 94%, specificity 86%
- Adding total bilirubin/alkaline phosphatase ratio → ~100% sensitivity and specificity
- Characteristic findings: Hemolytic anemia, markedly elevated bilirubin, very low alkaline phosphatase
- Important: Acute phase reactants (ceruloplasmin, alpha-1 antitrypsin, ferritin) have little diagnostic value in ALF
HSV Hepatitis:
- Frequently anicteric (bilirubin may not rise significantly)
- Key clinical clue: Fever present in ~98% of cases
- AST/ALT may reach into the thousands
- Diagnosis: HSV PCR preferred over serology (serology too slow)
- Recommendation: Start empirical antiviral therapy immediately while awaiting PCR results — do not wait
- Historical data: Diagnosis made at autopsy in >57% of cases — underscoring need for early suspicion
Mushroom Poisoning (Amanita phalloides):
- Presents with severe GI symptoms mimicking gastroenteritis
- Highly lethal; commonly associated with acute kidney injury (AKI)
- Management considerations:
- Aggressive IV hydration
- Penicillin G and/or silymarin (milk thistle) may have a role
- Nasogastric suction and/or cholestyramine to interrupt enterohepatic circulation of toxin
- Liver transplantation may be required
Prognostic Tools
- King's College Criteria (KCC): Developed 1993; remains a benchmark prognostic tool
- Non-acetaminophen poor prognostic indicators include: age >40, jaundice >7 days before encephalopathy, bilirubin >300 µmol/L (~17 mg/dL), unfavorable etiology
- Additional prognostic modalities:
- APACHE II score (acetaminophen cases)
- MELD score
- CT-measured liver volume (low volume = poor prognosis)